Mobble
Health · Cancer research · published 2026-08-14 · via Oncology News Central

August 2026 Cancer Research Integrity Watch: Retraction and Betting Markets

A 2019 study on tuberous sclerosis complex tumors from Brigham and Women's Hospital was retracted due to duplicated images and unreliable data. Additionally, prediction platforms now allow wagers on clinical trial outcomes and FDA approvals, raising ethical questions about potential conflicts of interest in cancer research.

Read the full article at Oncology News Central →
Related stories
Study highlights industry's dominance in cancer research amid federal funding cuts · Cancer research
This summary is AI-generated and original to Mobble; the linked article is the authoritative source. Original headline: “Cancer Research Concerns: Rapid Roundup for August 2026.” Browse more stories.